Greco Medical Group involved in the largest PRP study for Hair
Platelet-Rich Plasma for Androgenetic Alopecia: A Pilot Study
Giovanni Schiavone, MD, Desanka Raskovic, MD, Joseph Greco, PhD, PA/C, and Damiano Abeni, MD, MPHx
The Plastic Surgery and Regenerative Surgery Unit, the Second Clinical Dermatology Unit, the Health Services Research Unit, IDI-IRCCS, Rome, Italy and the Greco Medical Group, Sarasota, Florida did this study.
It was supported the Italian Ministry of Health in 2012-2013 and Published by the American Society for Dermatologic Surgery, Inc. in The Journal of Dermatologic Surgery, Sept, 2014.
RESULTS: Sixty-four consecutive patients were enrolled. Some improvement was seen in all patients by 1 evaluator and in 62 by the other. The mean change in clinical rating was 3.2 (95% confidence interval [CI], 2.9– 3.5) and 3.9 (95% CI, 3.5–4.3), and the proportion of patients reaching a clinically important difference was 40.6% and 54.7%, according to the 2 evaluators, respectively.
In simple terms, we now know the growth factors or proteins in PRP:
- Play a key role in communication with the stem cells in the hair shaft to initiate the hair cycle
- Play a role in hair canal formation
- Control of hair growth and follicle size.
- Stimulating hair growth by prolonging the anagen phase (growth phase) of the hair cycle.
- Increase hair shaft diameter
- Increased vessels around follicles